Dimitrios Chondros

After Ending Cancer Drug Program, Halozyme Predicts Profits in 2020

After Ending Cancer Drug Program, Halozyme Predicts Profits in 2020

1 month ago   |   Xconomy

Halozyme suffered a setback in November when its investigational pancreatic drug failed a Phase 3 clinical trial , but its CEO says the biotech's drug delivery technology will...
Read more ...

2019 Newly Elevated Fellows

One year ago   |   EMBS

IEEE Fellow is a distinction reserved for select IEEE members whose extraordinary accomplishments in any of the IEEE fields of interest are deemed fitting of this prestigious...
Read more ...

Sensor Informatics

One year ago   |   Journal of Biomedical   |   6 articles

In this issue, vol. 22, issue 6, November 2018, 7 papers are published related to the topic Sensor Informatics. Please click below to view them in IEEE XPLORE. Particle...
Read more ...

Medical Informatics

Medical Informatics

One year ago   |   Journal of Biomedical   |   3 articles

In this issue, vol. 22, issue 4, July 2018, 4 papers are published related to the topic Medical Informatics. Please click below to view them in IEEE XPLORE. A Trust Model for...
Read more ...

Halozyme Initiates Clinical Trial Of PEGPH20 With Anti-PDL1 Immunotherapy In Cholangiocarcinoma And Gallbladder Cancer Patients

2 years ago   |   San Diego Biotechnology   |   3 articles

PEGPH20, atezolizumab Combination to be Evaluated Under Clinical Collaboration SAN DIEGO, Oct. 16, 2017 /PRNewswire/ - Halozyme Therapeutics, Inc. today announced initiation of...
Read more ...

Special Section: MobiHealth 2014, IEEE HealthCom 2014, and IEEE BHI 2014

Special Section: MobiHealth 2014, IEEE HealthCom 2014, and IEEE BHI 2014

3 years ago

Metin Akay; Gouenou Coatrieux; Yang Hao; Dimitrios I. Fotiadis; Andrew Laine; Benny Lo; Konstantina S. Nikita; Norbert Noury; Joel Rodrigues; May D. Wang In this special...
Read more ...

Special Section: Enabling Technologies for Parkinson's Disease Management

Special Section: Enabling Technologies for Parkinson's Disease Management

3 years ago   |   36 articles

Parkinson's disease is the most common neurological movement disorder, with a prevalence of up to 2% in the elderly. The new research published in this Special issue represents...
Read more ...


Register you to post on BioTech Mag

Free Registration

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Invetx Fetches $15M to Develop Biologic Drugs for Man's Best Friend

Invetx Fetches $15M to Develop Biologic Drugs for Man's Best Friend

Veterinarians have a saying that a cat is not a small dog, says Invetx CEO Juergen Horn. Obviously, a dog of any size isn't the same as a human. But Horn, a veterinarian, says... Read more ...

Lundbeck's Alder Bio Bet Pays Off With FDA Approval of Migraine Drug

Lundbeck's Alder Bio Bet Pays Off With FDA Approval of Migraine Drug

A migraine drug that Lundbeck added to its pipeline via its nearly $2 billion acquisition of Alder BioPharmaceuticals won FDA approval on Friday. The drug, eptinezumab , is... Read more ...

IAmScience George Stewart

IAmScience George Stewart

By Becca Wolf | Bond LSC Medical bacteriologist, George Stewart has had a few stops along the way before he got to Bond LSC in 2004. Having done schooling and research at... Read more ...

Arima Genomics Completes Series A Financing

SAN DIEGO--Arima Genomics, Inc., a company focused on research tools to accelerate the understanding of genome sequence and structure toward their role in human health and... Read more ...

Viking Therapeutics to Participate in Upcoming Investor Conferences

SAN DIEGO, Feb. 24, 2020 /PRNewswire/ - Viking Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and... Read more ...

Molecular characterization and overexpression analyses of secologanin...

Abstract Camptothecin is a high-value anti-cancerous compound produced in many taxonomically unrelated species. Its biosynthesis involves a complex network of pathways and a... Read more ...

Modulation of the Purine Pathway for Riboflavin Production in Flavinogenic...

Riboflavin is an indispensable nutrient for humans and animals, since it is the precursor of the essential coenzymes FMN and FAD, involved in variety of metabolic reactions... Read more ...

A Critical Review of Genome Editing and Synthetic Biology Applications in...

Being the green gold of the future, microalgae and cyanobacteria have recently attracted considerable interest worldwide, for they can be used to produce different kinds of... Read more ...

Biodegradation of penicillin G from industrial bacteria residue by...

An efficient biodegradation-strengthening approach was developed to improve penicillin G degradation from industrial bacterial residue in an expanded bed adsorption bioreactor... Read more ...

More clues for how the monkeyflower got its spots

The monkeyflower, or Mimulus, though possessing a relatively simple genome is able to produce a stunning array of pigmentation patterns. A team of researchers is one step... Read more ...